tiprankstipranks
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market
Holding TCRX?
Track your performance easily

TScan Therapeutics (TCRX) Cash flow

180 Followers

TScan Therapeutics Cash Flow

TCRX's free cash flow for Q3 2024 was $-29.29M. For the 2024 fiscal year, TCRX's free cash flow was decreased by $6.22M and operating cash flow was $-27.92M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -107.18M$ -61.36M$ -66.50M$ -48.68M$ -3.02M$ -12.52M
Investing Cash Flow
$ -77.99M$ -60.76M$ -4.22M$ -9.94M$ -4.24M$ -1.25M
Financing Cash Flow
$ 163.09M$ 135.44M$ 29.36M$ 189.67M$ 288.00K$ 34.81M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 669.27M$ 138.39M$ 125.06M$ 166.44M$ 35.39M$ 42.36M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 3.01M$ 3.00M$ 660.00K---
Issuance Of Capital Stock
$ 33.13M$ 42.41M$ 193.00K$ 89.65M$ 0.00$ 34.81M
Issuance Of Debt
--$ 29.03M---
Repayment Of Debt
--$ -324.00K---
Free Cash Flow
$ -110.58M$ -64.50M$ -70.73M$ -58.62M$ -7.26M$ -13.77M
Domestic Sales
------
Foreign Sales
------
Currency in USD

TScan Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis